1. Home
  2. HROW vs RQI Comparison

HROW vs RQI Comparison

Compare HROW & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$34.10

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Quality Income Realty Fund Inc

RQI

Cohen & Steers Quality Income Realty Fund Inc

HOLD

Current Price

$12.45

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
RQI
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HROW
RQI
Price
$34.10
$12.45
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$71.14
N/A
AVG Volume (30 Days)
924.6K
430.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
8.20%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$44.68
N/A
Revenue Next Year
$40.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.85
$10.39
52 Week High
$54.98
$13.39

Technical Indicators

Market Signals
Indicator
HROW
RQI
Relative Strength Index (RSI) 27.80 39.83
Support Level $30.55 $12.14
Resistance Level $40.64 $12.63
Average True Range (ATR) 2.54 0.20
MACD -1.45 -0.13
Stochastic Oscillator 2.31 11.17

Price Performance

Historical Comparison
HROW
RQI

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About RQI Cohen & Steers Quality Income Realty Fund Inc

COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.

Share on Social Networks: